{
    "2021-09-01": [
        [
            {
                "time": "",
                "original_text": "长春高新：公司生长激素产品目前主要在国内销售",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "国内销售"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "长春高新控股子公司获药品补充申请批件并成药品上市许可持有人",
                "features": {
                    "keywords": [
                        "长春高新",
                        "控股子公司",
                        "药品补充申请",
                        "上市许可"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医美行业强化监管 安徽省IVD集采结果公布",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医美行业",
                        "强化监管",
                        "安徽省IVD集采"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "长春高新(000661.SZ)子公司华康药业成为小儿健胃宁口服液等药品上市许可持有人",
                "features": {
                    "keywords": [
                        "长春高新",
                        "华康药业",
                        "小儿健胃宁口服液",
                        "上市许可"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "长春高新：子公司6个药品获得药品补充申请批件",
                "features": {
                    "keywords": [
                        "长春高新",
                        "子公司",
                        "药品补充申请",
                        "批件"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业月报：智飞生物新冠疫苗III期数据优异 对变异株仍然有效",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "智飞生物",
                        "新冠疫苗",
                        "III期数据",
                        "变异株"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}